ONSD as an ICP Marker in vNOTES and TLH
Effect of Surgical Approach on Optic Nerve Sheath Diameter as a Surrogate Marker of Intracranial Pressure: A Comparison Between vNOTES and Total Laparoscopic Hysterectomy
1 other identifier
interventional
66
1 country
1
Brief Summary
Patients undergoing conventional total laparoscopic hysterectomy (TLH) are typically placed in the Trendelenburg position with intraabdominal carbon dioxide (CO₂) insufflation. These factors may contribute to intraoperative complications such as lymphedema, impaired pulmonary function, and increased intracranial pressure. Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES), a novel minimally invasive technique, provides retroperitoneal or transperitoneal access through the vaginal route and offers the potential for shorter operative times and lower intraabdominal pressure requirements. This study aims to evaluate whether the vNOTES technique can reduce intraoperative and postoperative complications compared with TLH. Particular attention will be given to hemodynamic parameters and changes in optic nerve sheath diameter as an indirect indicator of intracranial pressure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedStudy Start
First participant enrolled
November 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 5, 2026
CompletedJanuary 7, 2026
January 1, 2026
1 month
November 18, 2025
January 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Optic nerve sheath diameter (ONSD) measured
All measurements were performed using a high-resolution ultrasound device equipped with a 7-13 MHz linear probe. The ultrasound gain and depth settings were standardized for all patients (depth: 4-5 cm; focus: at the level of the optic disc). Patient Position: Measurements were obtained with patients in the supine position. The eyes were kept closed, and sterile ultrasound gel was applied without exerting pressure on the globe. The probe was gently placed on the upper eyelid, and measurements were taken in the transverse plane. The optic nerve sheath diameter was measured 3 mm distal to the optic disc, from outer edge to outer edge (outer-to-outer).
From baseline (before induction) to 10, 30, 60, and 90 minutes after Trendelenburg and CO₂ insufflation, and 10 minutes after desufflation.
Secondary Outcomes (9)
Blood pressure measurement
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
Measurement of heart rate
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
intraabdominal pressure
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
end-tidal CO₂ (EtCO₂)
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
peak airway pressure
It will be recorded 10 minutes before induction of anesthesia and every 15 minutes after intubation until the end of the operation.
- +4 more secondary outcomes
Study Arms (2)
vNOTES Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter
EXPERIMENTALVajinal natural orifice transluminal endoscopic surgery (vNOTES): In the vNOTES group, the surgery was performed using a transvaginal approach with a self-retaining vaginal port. Following colpotomy, CO₂ insufflation was applied through the vaginal port, ensuring intra-abdominal pressure did not exceed 15 mmHg. The procedure involved occlusion and ligation of the uterine artery under direct endoscopic visualization, followed by sampling through the vaginal route. Pneumoperitoneum was released before closing the vaginal vault. The uterus was then removed through the vaginal route.
Total Laparoscopic Hysterectomy for Assessment of Intraoperative Optic Nerve Sheath Diameter
ACTIVE COMPARATORTotal laparoscopic hysterectomy (TLH): In the TLH group, the surgical procedure was performed under standard laparoscopic conditions using a 10 mm umbilical camera port and two 5 mm accessory trocars. CO₂ insufflation was initiated to maintain intra-abdominal pressure below 15 mmHg. The uterus is dissected using a bipolar vessel sealing device, and the specimen is removed transvaginally. The vaginal cuff and abdominal trocar entries are sutured laparoscopically under direct visualization.
Interventions
vNOTES: In the vNOTES group, the surgery was performed using a transvaginal approach with a self-retaining vaginal port. Following colpotomy, CO₂ insufflation was applied through the vaginal port, ensuring intra-abdominal pressure did not exceed 15 mmHg. The procedure involved occlusion and ligation of the uterine artery under direct endoscopic visualization, followed by sampling through the vaginal route. Pneumoperitoneum was released before closing the vaginal vault. The uterus was then removed through the vaginal route.
In the TLH group, the surgical procedure was performed under standard laparoscopic conditions using a 10 mm umbilical camera port and two 5 mm accessory trocars. CO₂ insufflation was initiated to maintain intra-abdominal pressure below 15 mmHg. The uterus is dissected using a bipolar vessel sealing device, and the specimen is removed transvaginally. The vaginal cuff and abdominal trocar entries are sutured laparoscopically under direct visualization.
Eligibility Criteria
You may qualify if:
- voluntary participation,
- elective laparoscopic hysterectomy scheduled by gynecology-oncology specialists,
- ASA physical status I-II
You may not qualify if:
- included unwillingness to participate,
- emergency surgery,
- age \<18 years,
- prior major pelvic or abdominal surgery,
- ASA ≥III,
- Chronic pulmonary disease, pulmonary hypertension, glaucoma, diabetic retinopathy, intracranial pathology (mass, hydrocephalus, optic neuritis), prior ocular or intracranial surgery, cardiac failure (EF \<40%), active infection, or systemic inflammatory diseases other than malignancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Diyarbakır, Outside of the US, 21070, Turkey (Türkiye)
Related Publications (1)
Guloglu H, Cetinkaya D, Oge T, Bilir A. Evaluation of the effect of trendelenburg position duration on intracranial pressure in laparoscopic hysterectomies using ultrasonographic optic nerve sheath diameter measurements. BMC Anesthesiol. 2024 Jul 15;24(1):238. doi: 10.1186/s12871-024-02624-4.
PMID: 39010013BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fatma Acil, M.D.
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the surgical interventions, blinding is not feasible. Both surgeons and outcome assessors are aware of group allocation. Participants may also recognize their assigned intervention based on the operative approach.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 18, 2025
First Posted
November 26, 2025
Study Start
November 27, 2025
Primary Completion
January 2, 2026
Study Completion
January 5, 2026
Last Updated
January 7, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- study completion + 6 months
- Access Criteria
- Researchers may request access to the de-identified IPD by contacting the principal investigator at:\[acilfatma@gmail.com\]. Requests will be evaluated by the investigators, and data will be shared after approval and completion of a data-sharing agreement."
De-identified individual participant data (IPD), including baseline demographic variables and primary/secondary outcome measures, will be shared.